Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis

Home Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis

Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis

Feb 13, 2019 | Posted by |

Disher T, Gullickson C, Singh B, et al. JAMA Pediatr. Published online January 22, 2019. doi:10.1001/jamapediatrics.2018.5044

This systematic review identifies Buprenorphine as being the most usueful treatment for neonatal abstinence syndrome.

https://jamanetwork.com/journals/jamapediatrics/article-abstract/2721247?guestAccessKey=46e1efdd-c3b5-4f2c-9ea0-89a42b0c8ef3&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamapediatrics&utm_content=olf&utm_term=012219

Back

Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis

Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis

Find us on